Global 7-Aminocephalosporanic Acid (7-ACA) Market Outlook 2017-2022

Published: Sep, 2017 | Pages: 100 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

7-Aminocephalosporanic acid or 7-ACA is a starting compound for the production of various semi-synthetic cephalosporins of different generations. These compounds are made by modification of the side chains at positions 3 and 7 of 7-aminocephalosporanic acid (7-ACA). It is used to produce many cepholosporins pharmaceutical bulks, such as cefazolin sodium, cefotaxime sodium, ceftriaxone sodium, cefoperazone sodium, ceftazime sodium, cefuroxime sodium and so on.

The report covers forecast and analysis for the 7-ACA market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the 7-ACA market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the 7-ACA market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global 7-ACA market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the 7-ACA market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Applications
• Cephalosporin Antibiotics

Key Regions
• North America
• Europe
• Asia Pacific
• China

Key Vendors
• CSPC
• Fujian Fukang
• Harbin Pharmaceutical
• Joincare
• NCPC
• Shandong Lukang
• 10+ companies covered

Key Questions Answered in this Report
• What will the market size be in 2022?
• What are the key factors driving the global 7-ACA market?
• What are the challenges to market growth?
• Who are the key players in the 7-ACA market?
• What are the market opportunities and threats faced by the key players?

 Table of Contents
Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Product Overview
3.2 Properties
3.3 Cephalosporin Antibiotics
3.4 Manufacturing Process

Part 4. Competitive Landscape
4.1 Global 7-Aminocephalosporanic Acid Market, by Volume 2012-2017
4.1.1 Overview
4.1.2 Global 7-Aminocephalosporanic Acid Market, by Volume, by Company
4.1.3 Top 5 Companies by Volume Share
4.2 Global 7-Aminocephalosporanic Acid Market, by Revenue 2012-2017
4.2.1 Overview
4.2.2 Global 7-Aminocephalosporanic Acid Market, by Revenue, by Company
4.2.3 Top 5 Companies by Revenue Share

Part 5. Market Dynamics
5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

Part 6. Cephalosporin Antibiotics
6.1 Overview
6.2 Types of Cephalosporin Antibiotics
6.3 Market

Part 7. Segmentation by Region
7.1 Global 7-Aminocephalosporanic Acid Volume by Region
7.1.1 North America
7.1.2 Europe
7.1.3 Asia-Pacific
7.1.4 China
7.2 Global 7-Aminocephalosporanic Acid Revenue by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia-Pacific
7.2.4 China

Part 8. Consumption by Pattern
8.1 North America
8.1.1 North American Demand
8.1.2 by Country (U.S., Canada)
8.2 Europe
8.2.1 European Demand
8.2.2 by Country (UK, France, Germany)
8.3 Asia-Pacific
8.3.1 Asia-Pacific Demand
8.3.2 by Country (China, India, Japan)

Part 9. 7-Aminocephalosporanic Acid Market Forecast
9.1 Global 7-Aminocephalosporanic Acid Market Size 2017-2022
9.2 Global 7-Aminocephalosporanic Acid Market by Region 2017-2022
9.2.1 North America
9.2.2 Europe
9.2.3 Asia-Pacific
9.2.4 China
9.3 Global 7-Aminocephalosporanic Acid Consumption 2017-2022
9.4 Global 7-Aminocephalosporanic Acid Market by Application 2017-2022

Part 10. Key Vendors
10.1 Company Profiles
10.2 Market Share
10.3 Financials

Part 11. Industry Activity
11.1 M&As, JVs and Partnership
11.2 Expansions & Shutdown
11.3 Other Developments

Part 12. Appendix
12.1 Abbreviations
12.2 Disclaimer